Janux Therapeutics, Inc.JANXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-750.53%
↓ 25% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-602.13%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -750.53% | +17.9% |
| 2024 | -914.12% | -4.0% |
| 2023 | -878.68% | -14.2% |
| 2022 | -769.28% | +14.7% |
| 2021 | -902.28% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |